The patient Experience
The future of personalized regenerative medicines is a lot closer than you think.
How Will Cell, Tissue, and Organ Replacements Work?
Many chronic conditions, such as diabetes, heart disease, and age-related blindness, result from damaged cells. Replacing these with healthy, lab-grown cells can restore function and improve health. Induced Pluripotent Stem Cells (iPSCs) enable personalized treatments tailored to each patient.
At Cellino, we’re making these transformative therapies more widely available.
Doctor’s Visit & Diagnosis
The patient consults their doctor and receives a diagnosis for a degenerative condition.
Personalized Therapy Prescription
The physician prescribes a cell-based treatment. The patient’s blood sample is sent to a nearby Cellino Regenerative Foundry.
Cell Regeneration & Production
At the Regenerative Foundry, the patient’s blood cells are converted into iPSCs, which are then transformed into the specific cell type needed for treatment. Examples include dopaminergic neurons for Parkinson’s, cardiac cells for heart disease, and retinal cells for vision loss.
Therapy Transplantation
The patient returns to their healthcare provider to receive a transplant of their customized cells, tissues, or organs designed to restore function and health.
Safe, Proven Therapies
At Cellino, patient safety is our top priority. Our forthcoming therapies meet rigorous FDA standards and are backed by scientific research. We caution against unregulated "stem cell clinics" that lack proper oversight and scientific validation.
Diseases Of Interest
Our impact and potential
890Mpatients affected by Obesity
400Mpatients affected by T2 Diabetes
21.5Mpatients affected by Alzheimer’s
850Mpatients affected by Chronic Kidney Disease
196Mpatients affected by Macular Degeneration
1Bpatients affected by Metabolic Syndrome
Clinical Trials
We share this list for informational purposes only, to offer resources on cutting-edge clinical trials involving personalized cells. It is not an endorsement of any specific trial. Over time, we will share any Cellino affiliations with these trials.
- Read more about "Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration"
Phase 1/2A: Recruiting
National Eye Institute
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
For Age-related Macular Degeneration
- Read more about "Phase 1/2a Study of ANPD001 in Parkinson Disease (ASPIRO)"
Phase 1/2A: Enrolling by Invitation
Aspen Neuroscience
Phase 1/2a Study of ANPD001 in Parkinson Disease (ASPIRO)
For Parkinson’s
- Read more about "Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease"
Phase 1: Recruiting
Heartworks, Inc.
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
For Congenital Heart Disease
- Read more about "Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease"
Phase 1: Recruiting
Oryon Cell Therapies
Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
For Parkinson’s
- Read more about "Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons"
Phase 1: Recruiting
Massachusetts General Hospital
Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
For Parkinson’s
